References
- Jin J, Sklar GE, Min Sen Oh V, et al. Factors affecting therapeutic compliance: a review from the patient's perspective. Ther Clin Risk Manag. 2008;4:269–286.
- Thompson L, McCabe R. The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry. 2012;12:87.
- Joosten EA, DeFuentes-Merillas L, de Weert GH, et al. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom. 2008;77:219–226.
- Sabaté E. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.
- Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105:164–172. Mar
- Marder SR. Overview of partial compliance. J Clin Psychiatry. 2003;64: 3–9.
- Weiden PJ, Kozma C, Grogg A, et al. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 2004;55:886–891. Aug
- Colom F, Vieta E, Tacchi MJ, et al. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005;7 Suppl 5: 24–31.
- Meehan J, Kapur N, Hunt IM, et al. Suicide in mental health in-patients and within 3 months of discharge. National clinical survey. Br J Psychiatry. 2006;188:129–134. Feb
- Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 2004;161:692–699. Apr
- Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv. 2001;52:805–811. Jun
- Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med. 2006;23:720–728. Jul
- Haynes RB, Sackett DL. Compliance with therapeutic regimens. Baltimore (MD): Johns Hopkins University Press; 1976.
- Sajatovic M, Velligan DI, Weiden PJ, et al. Measurement of psychiatric treatment adherence. J Psychosom Res. 2010;69:591–599.
- Velligan DI, Weiden PJ, Sajatovic M, et al. Expert consensus panel on adherence problems in serious and persistent mental illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70: 1–46. quiz 47-8.
- Murru A, Pacchiarotti I, Amann BL, et al. Treatment adherence in bipolar I and schizoaffective disorder, bipolar type. J Affect Disord. 2013;151:1003–1008. Dec
- Leclerc E, Mansur RB, Brietzke E. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord. 2013;149:247–252. Jul
- Czobor P, Van Dorn RA, Citrome L, et al. Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol. 2015;25:1158–1166. Aug
- Gibson S, Brand SL, Burt S, et al. Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. BMC Psychiatry. 2013; 13:153.
- Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol. 2003;13 Suppl 3:S69–S75. Sep
- Holma IA, Holma KM, Melartin TK, et al. Treatment attitudes and adherence of psychiatric patients with major depressive disorder: a five-year prospective study. J Affect Disord. 2010;127:102–112. Dec
- Arvilommi P, Suominen K, Mantere O, et al. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study . J Affect Disord. 2014;155:110–117. Feb
- Gray R, Bressington D, Ivanecka A, et al. Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? A systematic review and meta-analysis. BMC Psychiatry. 2016;16:90.
- Coodin S, Staley D, Cortens B, et al. Patient factors associated with missed appointments in persons with schizophrenia. Can J Psychiatry. 2004;49:145–148. Feb
- Aaltonen K, Näätänen P, Heikkinen M, et al. Differences and similarities of risk factors for suicidal ideation and attempts among patients with depressive or bipolar disorders. J Affect Disord. 2016; 193:318–330.
- Karpov B, Joffe G, Aaltonen K, et al. Anxiety symptoms in a major mood and schizophrenia spectrum disorders. Eur Psychiatry. 2016; 37:1–7.
- World Health Organization. International classification of disease. 10th ed. Geneva: WHO; 1992.
- Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561–571.
- Norman SB, Cissell SH, Means-Christensen AJ, et al. Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS). Depress Anxiety. 2006;23:245–249.
- Zanarini MC, Vujanovic AA, Parachini EA, et al. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003; 17:568–573.
- Babor TF, Saunders J, Grant M. AUDIT: the alcohol use disorder identification test: guidelines for use in primary health care. Geneva (Switzerland): World Health Organization; 1992.
- IBM Corp. IBM SPSS Statistics for Windows, Version 22.0. Armonk (NY): IBM Corp; 2013.
- Bø B, Ottesen ØH, Gjestad R, et al. Patient satisfaction after acute admission for psychosis. Nord J Psychiatry. 2016;70:321–328. Jul
- Rettenbacher MA, Hofer A, Eder U, et al. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry. 2004;65:1211–1218. Sep
- De Las Cuevas C, Peñate W. Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence. Hum Psychopharmacol Clin Exp. 2015;30:377–383. Sep
- Yalcin-Siedentopf N, Wartelsteiner F, Kaufmann A, et al. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics. Int J Neuropsychopharmacol. 2014;18:pyu091.
- Sajatovic M, Levin JB, Sams J, et al. Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder. Bipolar Disord. 2015;17:653–661. Sep
- Nielsen RE, Lindström E, Nielsen J, et al. DAI-10 is as good as DAI-30 in schizophrenia. Eur Neuropsychopharmacol. 2012;22:747–750. Oct
- Jónsdóttir H, Opjordsmoen S, Birkenaes AB, et al. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. J Clin Psychopharmacol. 2010;30:169–175. Apr
- Grinshpoon A, Lerner Y, Hornik-Lurie T, et al. Post-discharge contact with mental health clinics and psychiatric readmission: a 6-month follow-up study. Isr J Psychiatry Relat Sci. 2011;48:262–267.
- Saxena S, Thornicroft G, Knapp M, et al. Resources for mental health: scarcity, inequity, and inefficiency. Lancet. 2007;370:878–889. Sep 8
- Malowney M, Keltz S, Fischer D, et al. Availability of outpatient care from psychiatrists: a simulated-patient study in three U.S. cities. Psychiatr Serv. 2015;66:94–96. Jan 1
- Fung KM, Tsang HW, Corrigan PW. Self-stigma of people with schizophrenia as predictor of their adherence to psychosocial treatment. Psychiatr Rehabil J. 2008;32:95–104. Fall
- Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24:143–155.
- Keyes KM, Hatzenbuehler ML, McLaughlin KA, et al. Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol. 2010;172:1364–1372.
- Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72:334–341.
- Wahlbeck K, Westman J, Nordentoft M, et al. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry. 2011;199:453–458.
- Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
- Yuodelis-Flores C, Ries RK. Addiction and suicide: a review. Am J Addict. 2015;24:98–104.
- Chien WT, Mui JH, Cheung EF, et al. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial. Trials. 2015;16:270.
- Melartin TK, Rytsala HJ, Leskela US, et al. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry. 2002;63:126–134.
- Mantere O, Suominen K, Leppämäki S, et al. The clinical characteristics of DSM-IV bipolar I and II disorders: baseline findings from the Jorvi Bipolar Study (JoBS). Bipolar Disord. 2004;6:395–405.